WAHINGTON — People with Type 2 diabetes who eat breakfast later, are more likely to have a higher Body Mass Indices (BMI).
According to a study conducted by the University of Illinois at Chicago, an ‘evening person’ is linked to higher body mass indices among people with Type 2 diabetes, and having breakfast later in the day seems to be what drives this association.
Obesity is common among people with Type 2 diabetes. Having an evening preference — waking up later and going to bed later — has been linked to an increased risk for obesity, but research is lacking regarding this phenomenon among people with Type 2 diabetes.
Researchers, led by Sirimon Reutrakul, wanted to determine if morning or evening preference among people with Type 2 diabetes was associated with an increased risk for higher BMI and if so, what specific factors about evening preference contributed to the increased risk.
Reutrakul and her colleagues recruited 210 non-shift workers living in Thailand with Type 2 diabetes for their study. Morning/evening preference was assessed using a questionnaire that focused on preferred time for waking up and going to bed; time of day spent exercising; and time of day spent engaged in a mental activity (working, reading, etc.).
Participants were interviewed regarding their meal timing, and daily caloric intake was determined via self-reported one-day food recalls. Weight measurements were taken and BMI was calculated for each participant. Sleep duration and quality were measured by self-report and questionnaire.
Self-reported average sleep duration was 5.5 hours/night. On average, participants consumed 1,103 kcal/day. The average BMI among all participants was 28.4 kg/m2 — considered overweight. Of the participants, 97 had evening preference and 113 had morning preference.
Participants with morning prefereEarly breakfast is important for people with Type 2 diabetesnce ate breakfast between 7 a.m. and 8:30 a.m., while participants with evening preference ate breakfast between 7:30 a.m. and 9 a.m.
Participants with morning preference had earlier meal timing, including breakfast, lunch, dinner and the last meal.
The researchers found that having more evening preference was associated with higher BMI. Caloric intake and lunch and dinner times were not associated with having a higher BMI.
Morning preference was associated with earlier breakfast time and lower BMI by 0.37 kg/m2.
“Later breakfast time is a novel risk factor associated with a higher BMI among people with Type 2 diabetes,” said Reutrakul. “It remains to be investigated if eating breakfast earlier will help with body weight in this population.”
Reutrakul speculated that later meal times may misalign the internal biological clock, which plays a role in circadian regulation.
The findings from the study are published in the journal Diabetic Medicine.
Diabetes drug might ease heart failure risk
A new research has showed that the diabetes drug Farxiga might do double-duty for patients, helping to ward off another killer, heart failure.
According to the findings were published in the New England Journal of Medicine to coincide with their presentation at the annual meeting of the American Heart Association in Chicago, Type 2 diabetics who took Farxiga saw their odds of hospitalization for heart failure drop by 27 percent compared to those who took a placebo.
Farxiga is a type of drug called a SGLT2 inhibitor. The compound is called dapagliflozin.
The study included more than 17,000 type 2 diabetes patients aged 40 and older. Nearly 7,000 had heart disease and more than 10,000 had numerous risk factors for heart disease, Wiviott’s group said.
Patients were randomly assigned to take a dummy placebo pill or 10 milligrams of Farxiga each day.
“When it comes to helping our patients control and manage blood glucose, the ‘how’ appears to be as important [as] the ‘how much,” said study author Dr Stephen Wiviott, a cardiovascular medicine specialist at Brigham and Women’s Hospital in Boston.
“When choosing a therapy, trial results like these can help us make an informed decision about what treatments are not only safe and effective for lowering blood glucose but can also reduce risk of heart and kidney complications,” Wiviott said in a hospital news release.
Taking the drug did not reduce the risk of heart attack, stroke and cardiovascular-related death, the research team noted. However, patients who took the drug did see healthy declines in their blood sugar levels, plus an added bonus: a 27 percent decrease in their risk of hospitalization for heart failure.
Their risk of kidney failure and death from kidney failure also fell, researchers noted.
Two other recent studies of this class of drugs show that they “robustly and consistently improve heart and kidney outcomes in a broad population of patients with diabetes,” Wiviott noted.
With Inputs from HealthDayFollow @gorkhapost
Unnecessary comments weaken judiciary-CJ Mishra
CDF provides Rs 5 million to Eye Hospital
Massive fire guts property worth millions in Itahari
‘Transit permit’ takes toll on herbal export
Deteriorating bridges increase road accidents in Bara and Rautahat
- Main News7 days ago
EU to lift its ban on Nepali aircraft soon: Minister Adhikari
- Main News6 days ago
Devotees throng in Hindu shrines to observe Bala Chaturdashi
- News5 days ago
Dr Bhattarai asks local governments to ensure good-governance
- Main News7 days ago
32 dead, 1 missing in Papua attacks, Indonesian police say